Pro-Life Movement in the United States

Author(s):  
Daniel K. Williams
Author(s):  
Ziad Munson

Religion, and particularly the Catholic Church, was at the center of the emergence and initial mobilization of the pro-life movement in the United States. The movement originated in Catholic opposition to the liberalization of abortion law beginning in the 1950s, and accelerated rapidly after 1973 when abortion was legalized nationwide by the Supreme Court. Protestants began entering the movement in large numbers beginning in the 1980s, which corresponded with a peak in the amount of antiabortion street protest (and violence). All forms of pro-life protest—educational outreach to influence public opinion, political and legal involvement to influence the legal status of abortion, the development of crisis pregnancy centers to persuade individual pregnant women to carry their pregnancies to term, and direct action against abortion providers—have their roots in this formative period of movement mobilization, and all have continued to be important elements of the movement over the last half century. All these forms of protest activity include a religious component. They involve activists of deep religious faith, motivated by religious ideas, using religious principles in arguments about abortion, and depending on the leadership and resources of religious organizations. But the role of religion in the movement is sometimes overstated. Religion has not been the sole source of support for the movement. Pro-life protest has always included activists and organizations that are partially or wholly outside these strands of religious influence. Religion has also been a frequent source of tension and conflict in the movement, in addition to being a source of support. And the relationship between religion and the movement in recent decades does not distinguish it from the underlying partisan political landscape in which it is now firmly rooted.


2016 ◽  
Vol 41 (2) ◽  
pp. 2-4
Author(s):  
John F. Brehany ◽  

When the FDA labeled ulipristal acetate (UPA; Ella is the product sold in the United States by HRA Pharma) an “emergency contraceptive,” Catholic and pro-life leaders criticized the decision, identified Ella as an abortifacient, and agreed it should not be used by Catholic institutions and providers.1 Ron Hamel, senior ethicist for the Catholic Health Association, shared this conclusion. In 2014, however, Hamel ended a review article by stating, “If, however, the consensus is correct, then there would seem to be sufficient moral certitude at this time to make use of UPA in Catholic hospitals.” Below I question whether a relevant consensus exists and argue that the scientific evidence militates against, rather than in favor of, use of UPA/Ella by Catholic providers.


Nature ◽  
1911 ◽  
Vol 88 (2195) ◽  
pp. 101-102
Author(s):  
E. J. R.

Author(s):  
A. Hakam ◽  
J.T. Gau ◽  
M.L. Grove ◽  
B.A. Evans ◽  
M. Shuman ◽  
...  

Prostate adenocarcinoma is the most common malignant tumor of men in the United States and is the third leading cause of death in men. Despite attempts at early detection, there will be 244,000 new cases and 44,000 deaths from the disease in the United States in 1995. Therapeutic progress against this disease is hindered by an incomplete understanding of prostate epithelial cell biology, the availability of human tissues for in vitro experimentation, slow dissemination of information between prostate cancer research teams and the increasing pressure to “ stretch” research dollars at the same time staff reductions are occurring.To meet these challenges, we have used the correlative microscopy (CM) and client/server (C/S) computing to increase productivity while decreasing costs. Critical elements of our program are as follows:1) Establishing the Western Pennsylvania Genitourinary (GU) Tissue Bank which includes >100 prostates from patients with prostate adenocarcinoma as well as >20 normal prostates from transplant organ donors.


Author(s):  
Vinod K. Berry ◽  
Xiao Zhang

In recent years it became apparent that we needed to improve productivity and efficiency in the Microscopy Laboratories in GE Plastics. It was realized that digital image acquisition, archiving, processing, analysis, and transmission over a network would be the best way to achieve this goal. Also, the capabilities of quantitative image analysis, image transmission etc. available with this approach would help us to increase our efficiency. Although the advantages of digital image acquisition, processing, archiving, etc. have been described and are being practiced in many SEM, laboratories, they have not been generally applied in microscopy laboratories (TEM, Optical, SEM and others) and impact on increased productivity has not been yet exploited as well.In order to attain our objective we have acquired a SEMICAPS imaging workstation for each of the GE Plastic sites in the United States. We have integrated the workstation with the microscopes and their peripherals as shown in Figure 1.


Sign in / Sign up

Export Citation Format

Share Document